Glickman Richard M [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Glickman Richard M

Create: Alert

All | News | Filings

Date Filed

Type

Description

01/26/2021

Glickman Richard M (Director) has filed a Form 4 on ESSA Pharma Inc.

Txns:

Granted 25,000 options to buy @ $7, valued at $175k

01/11/2021

Form 4 - Statement of changes in beneficial ownership of securities:

10/01/2020

Glickman Richard M (Director) has filed a Form 3 on ESSA Pharma Inc.

01/25/2016

Form SC 13D - General statement of acquisition of beneficial ownership:

02/15/2007

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

02/14/2006

Glickman Richard M reports a 6.6% stake in Aspreva Pharmaceuticals Corporation

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy